Laura Mercier Flawless Skin Daily Face Shield Spf 40
Octinoxate, Titanium Dioxide
Gurwitch Products, Llc
Human Otc Drug
NDC 65342-2340Laura Mercier Flawless Skin Daily Face Shield Spf 40 also known as Octinoxate, Titanium Dioxide is a human otc drug labeled by 'Gurwitch Products, Llc'. National Drug Code (NDC) number for Laura Mercier Flawless Skin Daily Face Shield Spf 40 is 65342-2340. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Laura Mercier Flawless Skin Daily Face Shield Spf 40 drug includes Octinoxate - 75 mg/mL Titanium Dioxide - 50 mg/mL . The currest status of Laura Mercier Flawless Skin Daily Face Shield Spf 40 drug is Active.
Drug Information:
| Drug NDC: | 65342-2340 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Laura Mercier Flawless Skin Daily Face Shield Spf 40 |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Octinoxate, Titanium Dioxide |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Gurwitch Products, Llc |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Liquid |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | OCTINOXATE - 75 mg/mL
TITANIUM DIOXIDE - 50 mg/mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 21 Apr, 2011 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 25 Jun, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part352 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2024 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | |
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| UNII: | |
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 65342-2340-1 | 30 mL in 1 TUBE (65342-2340-1) | 19 Dec, 2017 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
For adult use only.
Product Elements:
Laura mercier flawless skin daily face shield spf 40 octinoxate, titanium dioxide water cyclomethicone butylene glycol dimethicone glycerin panthenol silicon dioxide sodium chloride glycyrrhizinate dipotassium eleuthero caprylyl glycol aluminum oxide phenoxyethanol edetate disodium octinoxate octinoxate titanium dioxide titanium dioxide
Warnings:
Warnings: for external use only. not to be swallowed
When Using:
Avoid contact with eyes. if contact occurs, rinse thoroughly with water
Dosage and Administration:
Directions for use: after moisturizing, shake bottle, and apply a small amount onto fingertips and smooth all over face and neck. for spf 40 protection, apply generously to cleansed skin prior to sum exposure. reapply as needed.
Stop Use:
Stop use and ask a doctor if rash or irritation develops.
Description:
Daily face shield spf 40 this weightless oil-free sunscreen goes on sheer, with no oily residue, to help shield skin from damaging sunrays and seasonal changes. daily face shield spf 40 helps: - create an invisible shield against damaging uva and uvb rays, preventing visible signs of aging - formulated with adaptogen technology which may help the skin adapt to seasonal changes. dermatologically and allergy tested to minimize the risk of allergy and irritation. dist. gurwitch products, l.l.c, po box 7568, new york, ny 10150 - abg int b.v. nl-venlo made in usa - www.lauramereler.com
Package Label Principal Display Panel:
Laura mercier flawless skin daily face shield spf 40 1 fl. oz/30 ml
Daily face shield spf 40 this weightless oil-free sunscreen goes on sheer, with no oily residue, to help shield skin from damaging sunrays and seasonal changes. daily face shield spf 40 helps: - create an invisible shield against damaging uva and uvb rays, preventing visible signs of aging - formulated with adaptogen technology which may help the skin adapt to seasonal changes. dermatologically and allergy tested to minimize the risk of allergy and irritation. dist. gurwitch products, l.l.c, po box 7568, new york, ny 10150 - abg int b.v. nl-venlo made in usa - www.lauramereler.com
Laura mercier a
Laura mercier b